S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
NASDAQ:ONCT

Oncternal Therapeutics (ONCT) News Today

$0.30
-0.01 (-3.22%)
(As of 10/3/2023 ET)
Compare
Today's Range
$0.30
$0.32
50-Day Range
$0.29
$0.40
52-Week Range
$0.26
$1.33
Volume
163,658 shs
Average Volume
332,023 shs
Market Capitalization
$17.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.10
SourceHeadline
MarketBeat logoStockNews.com Begins Coverage on Oncternal Therapeutics (NASDAQ:ONCT)
americanbankingnews.com - September 28 at 3:16 AM
msn.com logoHC Wainwright & Co. Upgrades Oncternal Therapeutics (ONCT)
msn.com - September 18 at 5:48 PM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Innate Pharma (IPHA)
markets.businessinsider.com - September 18 at 7:34 AM
finance.yahoo.com logoWe're A Little Worried About Oncternal Therapeutics' (NASDAQ:ONCT) Cash Burn Rate
finance.yahoo.com - September 17 at 9:56 AM
msn.com logoCantor Fitzgerald Reiterates Oncternal Therapeutics (ONCT) Neutral Recommendation
msn.com - September 9 at 4:58 AM
finance.yahoo.com logoOncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board
finance.yahoo.com - September 7 at 10:16 AM
finance.yahoo.com logoQ2 2023 Oncternal Therapeutics Inc Earnings Call
finance.yahoo.com - August 12 at 3:51 PM
finance.yahoo.com logoOncternal Therapeutics Provides Business Update and Announces Second Quarter 2023 Financial Results
finance.yahoo.com - August 11 at 3:07 AM
markets.businessinsider.com logoWhat Wall Street expects from Oncternal Therapeutics's earnings
markets.businessinsider.com - August 9 at 1:28 PM
finance.yahoo.com logoOncternal Therapeutics Receives FDA Study May Proceed Letter for ONCT-534, its Novel Dual-action Androgen Receptor Inhibitor, for the Treatment of Patients with Advanced Prostate Cancer
finance.yahoo.com - August 3 at 5:46 PM
finance.yahoo.com logoOncternal Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results
finance.yahoo.com - August 3 at 5:46 PM
finance.yahoo.com logoONCT - Oncternal Therapeutics, Inc.
finance.yahoo.com - July 27 at 12:11 AM
markets.businessinsider.com logoKyowa Kirin Appoints Gunnar F. Kaufmann, Ph.D., as Chief Research Officer, North America
markets.businessinsider.com - June 21 at 12:49 PM
morningstar.com logoOncternal Therapeutics Inc ONCT Stock Quote
morningstar.com - June 10 at 3:04 PM
finance.yahoo.com logoOncternal Therapeutics Announces First Patient Dosed in Phase 1/2 Study of ROR1 targeting autologous CAR T, ONCT-808, in patients with relapsed or refractory aggressive B-cell lymphoma
finance.yahoo.com - June 8 at 6:33 PM
msn.com logoHC Wainwright & Co. Reiterates Oncternal Therapeutics (ONCT) Neutral Recommendation
msn.com - June 6 at 4:20 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Hold Rating for Oncternal Therapeutics (ONCT)
markets.businessinsider.com - June 6 at 8:15 AM
finance.yahoo.com logoOncternal Therapeutics to Participate at the 2023 Jefferies Healthcare Conference
finance.yahoo.com - May 31 at 8:45 PM
markets.businessinsider.com logoBTIG Sticks to Their Buy Rating for Shattuck Labs (STTK)
markets.businessinsider.com - May 10 at 9:12 AM
markets.businessinsider.com logoBTIG Keeps Their Buy Rating on Xencor (XNCR)
markets.businessinsider.com - May 9 at 7:55 AM
finance.yahoo.com logoOncternal Therapeutics First Quarter 2023 Earnings: Revenues Beat Expectations, EPS In Line
finance.yahoo.com - May 6 at 8:30 AM
msn.com logoOncternal Therapeutics GAAP EPS of -$0.20 in-line, revenue of $0.2M beats by $0.06M
msn.com - May 4 at 8:00 PM
finance.yahoo.com logoOncternal Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
finance.yahoo.com - May 4 at 8:00 PM
msn.com logoOncternal Therapeutics: Q1 Earnings Insights
msn.com - May 4 at 8:00 PM
finance.yahoo.com logoOncternal Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
finance.yahoo.com - May 4 at 8:00 PM
uk.finance.yahoo.com logoWill Nektar Therapeutics (NKTR) Report Negative Earnings Next Week? What You Should Know
uk.finance.yahoo.com - May 2 at 1:26 PM
finance.yahoo.com logoOncternal Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results
finance.yahoo.com - April 27 at 8:21 PM
finance.yahoo.com logoOncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological Malignancies and Solid Tumors
finance.yahoo.com - April 13 at 6:40 PM
marketwatch.com logoOncternal Therapeutics Shares Plummet 52% As it Will Close Two Zilovertamab Studies
marketwatch.com - April 5 at 8:51 AM
msn.com logoBrookline Capital Downgrades Oncternal Therapeutics (ONCT)
msn.com - April 5 at 8:51 AM
msn.com logoOppenheimer Downgrades Oncternal Therapeutics (ONCT)
msn.com - April 5 at 8:51 AM
msn.com logoOncternal Craters after Halting Two Clinical Studies
msn.com - April 4 at 7:55 PM
marketwatch.com logoOncternal Therapeutics Heads for All-Time Low on Closing of 2 Zilovertamab Studies
marketwatch.com - April 4 at 2:54 PM
msn.com logoOncternal (ONCT) Down on Restructuring Plan to Extend Runway
msn.com - April 4 at 2:54 PM
msn.com logoWhy AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
msn.com - April 4 at 9:54 AM
markets.businessinsider.com logoOncternal Therapeutics (ONCT) was downgraded to a Hold Rating at H.C. Wainwright
markets.businessinsider.com - April 4 at 9:54 AM
msn.com logoWhy Is Oncternal Therapeutics (ONCT) Stock Down 62% Today?
msn.com - April 4 at 9:54 AM
marketwatch.com logoStocks to Watch: Histogen, Exela Technologies, Oncternal Therapeutics
marketwatch.com - April 4 at 12:15 AM
benzinga.com logoOncternal Therapeutics Announces Strategic Reprioritization and Capital Preservation, Extends Cash Runway into 2025
benzinga.com - April 3 at 7:15 PM
finance.yahoo.com logoOncternal Therapeutics Announces Strategic Reprioritization and Capital Preservation, Extends Cash Runway into 2025
finance.yahoo.com - April 3 at 7:15 PM
marketbeat.com logo
marketbeat.com - April 3 at 4:03 PM
finance.yahoo.com logoCompanies Like Oncternal Therapeutics (NASDAQ:ONCT) Could Be Quite Risky
finance.yahoo.com - April 2 at 2:20 PM
finance.yahoo.com logoOncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - March 27 at 12:27 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT) and Viracta Therapeutics (VIRX)
markets.businessinsider.com - March 14 at 9:18 AM
seekingalpha.com logoOncternal Therapeutics, Inc. (ONCT) Q4 2022 Earnings Call Transcript
seekingalpha.com - March 11 at 11:04 PM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Oncternal Therapeutics (ONCT), Helius Medical Technologies (HSDT)
markets.businessinsider.com - March 11 at 8:24 AM
msn.com logoOncternal Therapeutics GAAP EPS of -$0.20 beats by $0.01, revenue of $0.17M misses by $0.11M
msn.com - March 9 at 6:25 PM
finance.yahoo.com logoOncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2022 Financial Results
finance.yahoo.com - March 9 at 6:25 PM
finance.yahoo.com logoOncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results
finance.yahoo.com - March 2 at 7:27 PM
msn.com logoOncternal Therapeutics (ONCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
msn.com - March 2 at 2:27 PM
Get Oncternal Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter.



ONCT Media Mentions By Week

ONCT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONCT
News Sentiment

0.93

0.68

Average
Medical
News Sentiment

ONCT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONCT Articles
This Week

1

1

ONCT Articles
Average Week

Get Oncternal Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ONCT) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -